Pharma Bio Services (PBSV)
OTHER OTC:PBSV
US Market
Holding PBSV?
Track your performance easily

Pharma Bio Services (PBSV) Income Statement

41 Followers

Pharma Bio Services Income Statement

Last quarter (Q3 2024), Pharma Bio Services's total revenue was $2.42M, a decrease of -47.01% from the same quarter last year. In Q3, Pharma Bio Services's net income was $-309.19K. See Pharma Bio Services’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Oct 23Oct 22Oct 21Oct 20Oct 19
Total Revenue
$ 11.75M$ 16.98M$ 19.40M$ 20.12M$ 21.56M$ 19.51M
Cost of Revenue
$ 8.41M$ 11.91M$ 14.52M$ 14.76M$ 14.90M$ 13.33M
Gross Profit
$ 3.34M$ 5.07M$ 4.88M$ 5.36M$ 6.67M$ 6.18M
Operating Expense
$ 4.01M$ 3.95M$ 3.71M$ 9.21M$ 4.44M$ 4.48M
Operating Income
$ -672.99K$ 1.12M$ 1.17M$ -3.85M$ 2.23M$ 1.70M
Net Non Operating Interest Income Expense
--$ 64.15K---
Other Income Expense
$ -519.84K$ 570.08K$ 13.42K$ -1.98M$ -64.46K$ -526.57K
Pretax Income
$ -153.15K$ 1.69M$ 1.19M$ -1.88M$ 2.29M$ 2.22M
Tax Provision
$ 114.34K$ 377.31K$ 181.68K$ 14.97M$ 239.09K$ 135.99K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -267.49K$ 1.31M$ 1.01M$ -2.09M$ 2.05M$ 2.09M
Basic EPS
---$ -0.09$ 0.09$ 0.09
Diluted EPS
---$ -0.09$ 0.09$ 0.09
Basic Average Shares
$ 91.85M$ 22.97M$ 23.00M$ 23.03M$ 23.00M$ 23.05M
Diluted Average Shares
$ 91.90M$ 23.00M$ 23.03M$ 23.16M$ 23.04M$ 23.11M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 12.43M$ 15.86M$ 18.22M$ 23.97M$ 19.34M$ 17.81M
Net Income From Continuing And Discontinued Operation
$ -267.49K$ 1.31M$ 1.01M$ -2.09M$ 2.05M$ 2.09M
Normalized Income
$ 1.11M$ 1.33M-$ -1.48M--
Interest Expense
------
EBIT
$ -333.68K$ 1.12M$ 1.19M$ -3.85M$ 2.23M$ 2.22M
EBITDA
$ -150.79K$ 1.31M$ 1.38M$ -3.78M$ 2.31M$ 2.32M
Currency in USD

Pharma Bio Services Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis